跳至主要内容
临床试验/jRCT1080224974
jRCT1080224974已完成1 期

Phase 1 clinical trial of Boron Neutron Capture Therapy (BNCT) using CICS-1 and SPM-011 for Malignant melanoma and angiosarcoma

Cancer Intelligence Care Systems, Inc1 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
1
主要终点
safety

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
干预模型
Single-center, open label, single armed study
主要目的
Treatment Purpose

入排标准

年龄范围
20age old over 至 85age old under(—)
性别
All

入选标准

  • 1.Patients with primary malignant melanoma or angiosarcoma diagnosed histopathologically
  • 2.Patients with superficial skin lesions whose maximum diameter of the target lesion is 15 cm or less
  • 3.Patients with lesions that are 6 cm or less from the skin surface to the deepest part of the tumor
  • 4.Patients with lesions in the head, neck, chest, or extremities
  • 5.Patients who do not have apparent abnormal values in the latest screening test within 28 days of registration

排除标准

  • 1.Patients with obvious disseminated lesions
  • 2.Patients who have undergone previous treatment of radiation therapy exceeding 75 Gy for the target lesion.
  • 3.Patients with active lesions / active multiple cancers in addition to the target lesion
  • 4.Patients with infections that require systemic treatment.
  • 5.Patients with active implantable medical devices
  • Patients with a history of BNCT treatment

结局指标

主要结局

safety

时间窗: study period

- Evaluate the safety of each dose level from the frequency of DLT occurrence - Evaluate the incidence of adverse events and failures during the study period

次要结局

  • Tumor shrinkage rate
  • Progression-free survival

研究者

研究点 (1)

Loading locations...

相似试验